Reference answer · 340b-program · reviewed quarterly
Last updated
Review cadence: quarterlyUnderlying federal data: refreshed weekly to annual per source
Q&A library · 340b-program

How can hospitals comply with 2026 manufacturer 340B contract pharmacy carve-outs?

Hospitals must adjust to 2026 manufacturer carve-outs by limiting 340B dispensing to in-house or specialty pharmacies and maintaining strict ESP data uploads. Compliance now depends on proving claim eligibility and preventing duplicate discounts, often requiring tighter data integration and realignment of contract pharmacy networks.

Related questions.

Q&A librarySourced · reviewed quarterly
340b-programHow is HRSA changing 340B drug diversion oversight for specialty pharmacies in 2026?340b-programHow does HRSA enforce 340B re-registration after hospital mergers in 2026?340b-programHow will HRSA verify 340B child site eligibility during 2026 audits?340b-programHow can hospitals maintain 340B eligibility for offsite clinics in 2026?340b-programHow will HRSA verify 340B patient definition compliance across multi-site systems in 2026?340b-programHow is HRSA enforcing 340B duplicate discount rules for Medicaid MCO claims in 2026?
Browse all canonical questions →